MAPT and Alzheimer disease: Because cellular rejuvenation linked to the reprograming of iPSC cells 25, 27, 28, our experiments using the iPSC-derived neurons may uncover only those cellular changes in AD vs control that are dictated by genetic changes in the somatic cells of donors, largely without the contribution from accumulated Aβ, tau, or environmental factors during the development of AD in humans and mouse models.